Market Share

Showing 3515 articles
Business

NuScale Power's SMR Bet: A Path to Wealth or a Nuclear Mirage?

NuScale Power holds a unique regulatory approval for its small modular reactor technology, positioning it at the forefront of a potential nuclear energy shift. Yet, with no commercial deployments and a canceled flagship project, investors face a high-stakes gamble between revolutionary disruption and fading promise.

Sanofi Halts mRNA Flu Vaccine Trial Amid Surging U.S. Influenza Season

French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.